Shenkman Capital Management »

Travere Therapeutics shares owned by Shenkman Capital Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Shenkman Capital Management from 13F filings

Historical chart of Shenkman Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Shenkman Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.2B 6.2M 1157.05
2025-06-30 $5.7B 5.6M 1006.41
2025-03-31 $7.2B 6.9M 1040.90

More positions owned by Shenkman Capital Management

Etsy Note 0.250% 6/1 (Principal)
Uniti Group Note 7.500%12/0 (Principal)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Duke Energy Corp Note 4.125% 4/1 (Principal)
Snap Note 0.500% 5/0 (Principal)
Southern Note 4.500% 6/1 (Principal)
Cms Energy Corp Note 3.375% 5/0 (Principal)
Global Pmts Note 1.500% 3/0 (Principal)
Varonis Sys Note 1.000% 9/1 (Principal)
Digitalocean Hldgs Note 12/0 (Principal)
Firstenergy Corp Note 4.000% 5/0 (Principal)
Guardant Health Debt 1.250% 2/1 (Principal)
Dropbox Note 3/0 (Principal)
Microchip Technology Note 0.750% 6/0 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)

View all positions for Shenkman Capital Management

Top funds holding Travere Therapeutics

Linden Advisors
D. E. Shaw & Co
Graham Capital Management
Advent Capital Management
Millennium Management
Lord, Abbett & Co
Point72 Asset Management
Oaktree Capital Management
Agf Management
Polar Capital Holdings
Affinity Asset Advisors
Henderson Group
Shenkman Capital Management
FMR
BlackRock

View all funds holding Travere Therapeutics